000 | 01594 a2200433 4500 | ||
---|---|---|---|
005 | 20250515122721.0 | ||
264 | 0 | _c20080730 | |
008 | 200807s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mdn194 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEngert, A | |
245 | 0 | 0 |
_aTreatment of lymphocyte-predominant Hodgkin lymphoma. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJun 2008 |
||
300 |
_aiv45-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBleomycin _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDacarbazine _xtherapeutic use |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHodgkin Disease _xclassification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphocytes _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRadiotherapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVinblastine _xtherapeutic use |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 19 Suppl 4 _gp. iv45-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdn194 _zAvailable from publisher's website |
999 |
_c18012238 _d18012238 |